| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Board Of Directors | CEO +3 more
2 companies
Abdun-Nabi Daniel is a CEO at Emergent BioSolutions Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 12 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2019 | APVO Aptevo Therapeutics Inc. | Board Of Directors | Buy | 16,667 | $0.90 | $15,000.30 | +18.0% | |
| Mar 4, 2019 | EBS Emergent Biosolutions Inc. | CEO | Sell | 14,565 | $58.11 | $846,328.46 | -9.3% | |
| Sep 17, 2018 | EBS Emergent Biosolutions Inc. | CEO | Sale+OE | 29,539 | $65.00 | $1,920,035.00 | -8.1% | |
| Sep 5, 2018 | EBS Emergent Biosolutions Inc. | CEO | Sale+OE | 90,776 | $60.18 | $5,463,230.26 | -20.0% | |
| Jun 5, 2018 | EBS Emergent Biosolutions Inc. | Chief Executive Officer | Sell | 15,785 | $52.11 | $822,614.75 | -7.4% | |
| Jan 2, 2018 | EBS Emergent Biosolutions Inc. | President &CEO | Sale+OE | 21,906 | $47.91 | $1,049,516.46 | -9.7% | |
| Dec 13, 2017 | EBS Emergent Biosolutions Inc. | President &CEO | Sale+OE | 20,000 | $45.99 | $919,800.00 | -8.9% | |
| Nov 3, 2017 | EBS Emergent Biosolutions Inc. | President &CEO | Sale+OE | 31,508 | $42.77 | $1,347,490.00 | -7.2% | |
| Sep 27, 2017 | EBS Emergent Biosolutions Inc. | President &CEO | Sale+OE | 15,000 | $39.92 | $598,770.00 | -6.8% | |
| Aug 31, 2017 | EBS Emergent Biosolutions Inc. | President &CEO | Sale+OE | 15,000 | $37.21 | $558,150.00 | -6.8% |